Topic: HPV

VCP Research Fellow and European Research Lead Emilie Karafillakis speaks to HPV World about HPV vaccination developments and its impact on the…

HPV World spoke to VCP Research Fellow Emilie Karafillakis about HPV vaccination…

There is considerable variation across, and even within, countries as to how HPV vaccination is offered and accepted. This review aimed to identify what interventions exist to promote uptake and how effective they are.

Read the 2022 instalment of the VCPs bi-annual research report “The State of Vaccine Confidence in the EU,” which monitors public attitudes to vaccines across the continent.

In this review article, examples of hesitancy regarding the measles–mumps–rubella (MMR), human papillomavirus (HPV), and COVID-19 vaccines are used to explore the multifaceted issues that fuel vaccine hesitancy. Each of these examples is part of a larger, more complex story.

In this journal article, we draw findings and insights from the VCP’s decade-long monitoring of media and social media and its related research efforts.

The aim of this qualitative study was to provide an in-depth exploration and comparison of French mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination.

This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on Lower Middle Income Countries and the significant barriers in the…

The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines,…

Dr. Abosede Lewu from Girlsaid Initiative describes his experience with HPV vaccine advocacy and…

Dr. Omolola Salako shares her experience with HPV vaccination in Nigeria.

Ishak Lawal from End Cervical Cancer Nigeria Initiative shares lessons learned from a HPV pilot demonstration in Nigeria.